Aspire Growth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-464
Closed -$219K 132
2026
Q1
$219K Buy
464
+1
+0.2% +$503 0.15% 114
2025
Q4
$216K Buy
+463
New +$215K 0.15% 118

Other funds holding HCA

Aspire Growth Partners's HCA Position: Q2 2026 in Review

Aspire Growth Partners sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 464 shares — an estimated $219K sold.

Aspire Growth Partners first reported a position in HCA in Q4 2025 and held it in 2 quarters. The position peaked at $219K in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Aspire Growth Partners reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Aspire Growth Partners sold 464 HCA Healthcare shares in Q2 2026, an estimated $219K.
  • Aspire Growth Partners first reported a position in HCA Healthcare in Q4 2025 and held it in 2 quarters.
  • Aspire Growth Partners's HCA Healthcare position peaked at $219K in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.